| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ARDELYX INC COM | 173,995 | 2,471,000 | 2.17% | ||
| 52 | NEUROCRINE BIOSCIE COM USD0.001 | 66,008 | 2,555,000 | 2.24% | ||
| 53 | CYTOKINETICS INC | 210,306 | 2,555,000 | 2.24% | ||
| 54 | APPLIED GENETIC TECHNOL CORP | 286,298 | 2,677,000 | 2.35% | ||
| 55 | INSULET CORPORATION | 73,484 | 2,769,000 | 2.43% | ||
| 56 | FOAMIX PHARMACEUTICALS LTD | 268,067 | 2,976,000 | 2.61% | ||
| 57 | DERMIRA INC COM | 98,800 | 2,997,000 | 2.63% | ||
| 58 | BEIGENE LTD | 119,841 | 3,638,000 | 3.20% | ||
| 59 | AERIE PHARMACEUTICALS INC COM | 98,370 | 3,723,000 | 3.27% | ||
| 60 | XENON PHARMACEUTICALS INC | 514,091 | 3,959,000 | 3.48% | ||
| 61 | Sunesis Pharmaceuticals, Inc. | 1,133,583 | 4,104,000 | 3.61% | ||
| 62 | GALAPAGOS NV | 66,068 | 4,241,000 | 3.73% | ||
| 63 | LOXO ONCOLOGY INC COM | 139,722 | 4,487,000 | 3.94% | ||
| 64 | ALDER BIOPHARMACEUTICALS INC | 221,013 | 4,597,000 | 4.04% | ||
| 65 | NXSTAGE MED INC COM | 236,119 | 6,189,000 | 5.44% | ||
| 66 | ATRICURE INC | 518,946 | 10,156,000 | 8.92% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000014, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
